NCT05452343View on ClinicalTrials.gov

A Study of CM310 in Subjects With Chronic Pruritus

PHASE2UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 30, 2022

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions
Chronic Pruritus of Unknown Origin
Interventions
BIOLOGICAL

CM310

600 mg (first doing) + 300 mg (subsequent dosing), once every two weeks

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT05452343 - A Study of CM310 in Subjects With Chronic Pruritus | Biotech Hunter | Biotech Hunter